Dr. Grandinetti is a drug discovery leader with 20 years of experience across multiple research disciplines and therapeutic areas. Prior to co-founding KymaThera, Dr. Grandinetti guided discovery biology at oncology-focused Kinnate Biopharma. She led programs from screening to development candidate selection, driving delivery of multiple IND-enabling studies and establishing productive external and academic collaborations.Previously at Vertex Pharmaceuticals, she was a key member of the team discovering and advancing candidates leading to FDA approved drugs, Trikafta® for cystic fibrosis and Journavx™ for pain, as well as advancing high-throughput cell-based screening platforms that informed numerous successful drug programs.

Earlier in her career, she held varied research positions at the Novartis Institutes for Biomedical Research and Shire Regenerative Medicine Unit and completed postdoctoral fellowships at New York University School of Medicine and The Scripps Research Institute.

white logo.